Role of the oncogenic Raf-1 in orchestration of discrete nuclear factor-κB-activating pathways

Molecular Cell Biology Research Communications

Volumn 4, Issue 6, 2001, Pages 381-389

  Liu, Qingyan ^a   Fan, Jianguo ^b   McMahon, Martin ^c   Prince, Alfred M ^a   Zhang, Pei ^a  

^a Lindsley F Kimball Res Inst N   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

I B; NF B; Proinflammatory cytokine; Raf 1; Signaling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYTOKINE; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ONCOPROTEIN; PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0035200949     PISSN: 15224724     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcbr.2001.0304     Document Type: Article

References (63)

1. NF-κB: Ten years after
2. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
3. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
4. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
5. rsk) phosphorylates the N-terminal regulatory domain of IκB-α and stimulates its degradation in vitro
6. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase
7. IKKε is part of a novel PMA-inducible IκB kinase complex
8. NF-κB activation: The IκB kinase revealed?
9. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways
10. Phosphorylation meets ubiquitination: The control of NF-κB activity
11. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
12. Unresponsiveness of MyD88-deficient mice to endotoxin
13. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
14. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
15. Bridging the gap: Composition, regulation, and physiological function of the IκB kinase complex
16. IKK-γ is an essential regulatory subunit of the IκB kinase complex
17. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
18. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis
19. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice
20. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: Additional defect in neurulation
21. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
22. IKK1-deficient mice exhibit abnormal development of skin and skeleton
23. Limb and skin abnormalities in mice lacking IKKα
24. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
25. NEMO/IKKγ-deficient mice model incontinentia pigmenti
26. Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
27. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti
28. Sequential protein kinase reactions controlling cell growth and differentiation
29. Transcriptional regulation by extracellular signals: Mechanisms and specificity
30. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
31. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
32. Ras effectors
33. Regulation of transcription by MAP kinase cascades
34. Direct interaction of Ras and the amino terminal region of Raf-1 in vitro
35. Complex formation between RAS and RAF and other protein kinases
36. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
37. Activation of Raf as a result of recruitment to the plasma membrane
38. Activation of the MAP kinase pathway by the protein kinase raf
39. Raf-1 activates MAP kinase-kinase
40. Nuclear localization and regulation of erk- and rsk-encoded protein kinases
41. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation
42. Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells
43. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1
44. Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways
45. Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation
46. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase
47. Cip1
48. IκB-β regulates the persistent response in a biphasic activation of NF-κB
49. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
50. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
51. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
52. Kip1 for restriction point control of the fibroblast cell cycle
53. Direct phosphorylation of IκB by IKKα and IKKβ: Discrimination between free and NF-κB-bound substrate
54. Sustained activation of the Raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells
55. Transient inhibition of interleukin 4 signaling by T cell receptor ligation
56. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases
57. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade
58. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
59. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
60. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
61. Phosphorylation and regulation of Raf by Akt (protein kinase B)
62. Ras enhances Myc protein stability
63. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases